Department of Cardiology, Nepal Mediciti Hospital, Lalitpur, Nepal.
Abstract
A 38-year-old man presented to the emergency department with ongoing chest pain. The patient had a sudden onset of central, crushing chest pain for 7 hours, with severity increasing in the last 2 hours. The symptoms were associated with sweating. He was a known case of hypertension and was on medication for the preceding 2 years. The patient was also prediabetic. His mother had hypertension and diabetes mellitus. There was no history of hypertension, diabetes mellitus, or cardiovascular disease in his siblings.
On general examination, the patient had an O2 saturation level of 95%, a pulse rate of 110 beats per minute, and a blood pressure of 110/90 mm Hg. On systemic examination, no abnormality was detected. Additionally, the complete blood count, renal function tests, blood sugar random test, and electrolytes were within normal limits. Electrocardiography demonstrated an ST elevation in the inferolateral leads. He also had a CPK-MB level of 82 IU/L and a troponin level of 11.6 IU/L. Echocardiography revealed a hypokinetic left ventricular inferior wall.
With a diagnosis of acute inferolateral wall myocardial infarction (MI), the patient was taken to the catheterization laboratory, where coronary angiography revealed normal coronary arteries. He was admitted to the CCU and was treated with aspirin, clopidogrel, low-molecular-weight heparin, atorvastatin, beta-blockers, anxiolytics, proton-pump inhibitors, and stool softeners. On the following day, cardiac magnetic resonance revealed curvilinear, confluent, and patchy subendocardial enhancement in the inferoposterior wall of the left ventricle. The features were compatible with MI. He was conservatively managed and was discharged on the fifth post-MI day.
DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. NEnglJMed.1980; 303(16):897–902.
Hjort M, Lindahl B, Baron T, et al. Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries. Am Heart J. 2018; 200:60–6.
Pasupathy S, Air T, Dreyer RP, et al . Systematic review of patients presenting with suspected myocardial infarction and non-obstructive coronary arteries. Circulation. 2015; 131(10): 861–70.
Collste O, Sorensson P, Frick M, et al. Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study. J Intern Med. 2013; 273(2):189–96.
Bairey Merz CN, Pepine CJ, Walsh MN, et al. Ischemia and No Obstructive Coronary Artery Disease (INOCA): developing evidence-based therapies and research agenda for the next decade.Circulation.2017; 135(11):1075–92.
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019; 40(3):237–69.
Agewall S, Beltrame JF, Reynolds HR, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017; 38(3):143–53.
Planer D, Mehran R, Ohman EM, et al. Prognosis of patients with non-ST-segment-elevation myocardial infarction and non-obstructive coronary artery disease: a propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circ Cardiovasc Interv.2014; 7(3):285–93.
Patel MR, Chen AY, Peterson ED, et al. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress Adverse Outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. AmHeartJ. 2006; 152(4):641–7.
Planer D, Mehran R, Ohman EM, et al. Prognosis of patients with non-ST-segment-elevation myocardial infarction and non-obstructive coronary artery disease: a propensity-matched analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circ Cardiovasc Interv. 2014; 7(3):285–93.
Safdar B, Spatz ES, Dreyer RP, et al. Presentation, clinical profile, and prognosis of young patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): results from the VIRGO study. J Am Heart Assoc. 2018;
Tamis-Holland JE, Jneid H, Reynolds HR, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association.Circulation.2019; 139(18):e891–e908.
Larsen AI, Nilsen DW, Yu J, et al. Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease(from the HORIZONS-AMI trial). AmJCardiol. 2013; 111(5):643–8.
Pasupathy S, Tavella R, Beltrame JF. Myocardial infarction with Non-obstructive coronary arteries (MINOCA): the past, present, and future management. Circulation. 2017; 135(16):1490–3.
Jia H, Abtahian F, Aguirre AD, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. JAmCollCardiol. 2013; 62(19):1748–58.
Reynolds HR, Srichai MB, Iqbal SN, et al. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011; 124(13):1414–25.
Khuddus MA, Pepine CJ, Handberg EM, et al. An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a sub-study from the National Heart, Lung and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). JIntervCardiol. 2010; 23(6):511–9.
Prasad A. Apical ballooning syndrome: an important differential diagnosis of acute myocardial infarction. Circulation. 2007 Feb; 115(5):e56–9.
Maznyczka AM, McCartney PJ, Oldroyd KG, et al. Risk stratification guided by the index of microcirculatory resistance and left ventricular end-diastolic pressure in acute myocardial infarction. Circ Cardiovasc Interv 2021; 14:e009529.
Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021; 42:1289–367.
Leurent G, Langella B, Fougerou C, et al. Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome, and unobstructed coronary arteries. Arch CardiovascDis. 2011; 104(3):161–70.
Stensaeth KH, Fossum E, Hoffmann P, et al. Clinical characteristics and role of early cardiac magnetic resonance imaging in patients with suspected ST-elevation myocardial infarction and normal coronary arteries.Int J CardiovascImaging. 2011; 27(3):355–65.
Avegliano GP, Huguet M, Costabel JP, et al. Cardiac magnetic resonance imaging in patients with chest pain, high troponin levels and absence of coronary artery obstruction. RevArgentCardiol.2011; 79(3):226–30.
Laraudogoitia Zaldumbide E, Perez-David E, Larena JA, et al. The value of cardiac magnetic resonance in patients with acute coronary syndrome and normal coronary arteries. RevEspCardiol.2009; 62(9):976–83.
Gerbaud E, Harcaut E, Coste P, et al. Cardiac magnetic resonance imaging for the diagnosis of patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. IntJCardiovascImaging. 2012; 28 (4):783–94.
Lindahl B, Baron T, Erlinge D, et al. Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with non-obstructive coronary artery disease. Circulation 2017; 135:1481–9
Nordenskjöld AM, Agewall S, Atar D, et al. Randomized evaluation of beta-blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): rationale and design. Am Heart J 2021; 231:96–104.
De Mello WC. The beneficial effect of eplerenone on cardiac remodeling and electrical properties of the failing heart. J Renin Angiotensin Aldosterone Syst 2006; 7:40–6.
Choo EH, Chang K, Lee KY, et al. Prognosis and predictors of mortality in patients suffering myocardial infarction with non-obstructive coronary arteries. J Am Heart Assoc 2019; 8:e011990.
Jernberg T, Attebring MF, Hambraeus K, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 2010; 96:1617–21
Sharma, R., Hirachan, A., Gautam, M., & Neupane, P. (2022). Myocardial Infarction With Nonobstructive Coronary Arteries: What Does an Interventionist Need to Know?. Iranian Heart Journal, 23(2), 130-135.
MLA
Ranjit Sharma; Anish Hirachan; Milan Gautam; Prabesh Neupane. "Myocardial Infarction With Nonobstructive Coronary Arteries: What Does an Interventionist Need to Know?". Iranian Heart Journal, 23, 2, 2022, 130-135.
HARVARD
Sharma, R., Hirachan, A., Gautam, M., Neupane, P. (2022). 'Myocardial Infarction With Nonobstructive Coronary Arteries: What Does an Interventionist Need to Know?', Iranian Heart Journal, 23(2), pp. 130-135.
VANCOUVER
Sharma, R., Hirachan, A., Gautam, M., Neupane, P. Myocardial Infarction With Nonobstructive Coronary Arteries: What Does an Interventionist Need to Know?. Iranian Heart Journal, 2022; 23(2): 130-135.
)